PTJ
AFIB

Paul Tudor Jones’s Acutus Medical Inc AFIB Stock Holding History

Paul Tudor Jones’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,365
Closed -$227K – 2897
2021
Q2 		$227K Buy
+13,365
New +$196K ﹤0.01% 1448
2020
Q4 		– Sell
-8,220
Closed -$245K – 1695
2020
Q3 		$245K Buy
+8,220
New +$250K 0.01% 1062

Other funds holding AFIB

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
KA
Kerrisdale Advisers Miami, Florida $399M AUM 42.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $179M AUM 5.77% 1-Year Est. Return

Paul Tudor Jones's AFIB Position: Q3 2021 in Review

Paul Tudor Jones sold out of Acutus Medical Inc (AFIB) in Q3 2021, closing a stake of 13,365 shares — an estimated $227K sold.

Paul Tudor Jones first reported a position in AFIB in Q3 2020 and held it in 2 quarters. The position peaked at $245K in Q3 2020. 70 funds tracked by Wall St. Rank hold AFIB as of Q3 2021.

  • Paul Tudor Jones reported no remaining Acutus Medical Inc position as of Q3 2021 after selling out during the quarter.
  • Paul Tudor Jones sold 13,365 Acutus Medical Inc shares in Q3 2021, an estimated $227K.
  • Paul Tudor Jones first reported a position in Acutus Medical Inc in Q3 2020 and held it in 2 quarters.
  • Paul Tudor Jones's Acutus Medical Inc position peaked at $245K in Q3 2020.
  • 70 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q3 2021.

Based on Tudor Investment Corp's 13F filing for Q3 2021, filed 15 Nov 2021.